Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 4/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | VDR | P11473 | 1/20 | 0.41 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | G6PD | P11413 | 1/20 | 0.39 |
| ▸ | GBA1 | P04062 | 1/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8378760 | 0.90 | ALDH1A1 (0.40) | GAAALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL9261221 | 0.88 | CA2 (0.40) | GAAALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL14779262 | 0.86 | GAA (0.46) | GAAALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL6686680 | 0.85 | LMNA (0.40) | GAAALDH1A1SMN1; SMN2KMT2AMEN1 | |
| SCHEMBL890724 | 0.85 | CA12 (0.50) | GAAALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL8345094 | 0.85 | GAA (0.45) | GAAALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL9486447 | 0.84 | CA2 (0.37) | GAAALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL10397640 | 0.83 | GAA (0.43) | GAAALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL92244 | 0.83 | CA2 (0.44) | GAAALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL766861 | 0.83 | CA2 (0.44) | GAAALDH1A1CYP3A4CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250257265-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT | NISSAN CHEMICAL CORPORATION (JP) | 2025-08-14 | — | — | US | disclosed |
| WO-2025127092-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2025-06-19 | — | — | WO | disclosed |
| WO-2025088969-A1 | COMPOSITION FOR FORMING CURED FILM, CURED FILM, ALIGNMENT MATERIAL, AND RETARDATION MATERIAL | 日産化学株式会社 | 2025-05-01 | — | — | WO | disclosed |
| WO-2025079671-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2025-04-17 | — | — | WO | disclosed |
| WO-2025079672-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2025-04-17 | — | — | WO | disclosed |
| EP-4528369-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT | Nissan Chemical Corporation (JP) | 2025-03-26 | — | — | EP | disclosed |
| WO-2025023309-A1 | COMPOSITION FOR FORMING CURED FILM, ALIGNMENT MATERIAL, AND PHASE-DIFFERENCE MATERIAL | 日産化学株式会社 | 2025-01-30 | — | — | WO | disclosed |
| WO-2024162344-A1 | POLYMER COMPOSITION AND SINGLE-LAYER RETARDATION MATERIAL | 日産化学株式会社 | 2024-08-08 | — | — | WO | disclosed |
| WO-2024080351-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2024-04-18 | — | — | WO | disclosed |
| WO-2023224114-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2023-11-23 | — | — | WO | disclosed |
| EP-2457964-A1 | COMPOSITION FORMING HEAT CURED FILM HAVING PHOTO ALIGNMENT PROPERTY | Nissan Chemical Industries, Ltd. (JP) | 2012-05-30 | — | — | EP | disclosed |
| US-20120114879-A1 | COMPOSITION FOR FORMING THERMOSET FILM HAVING PHOTO ALIGNMENT PROPERTIES | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-05-10 | — | — | US | disclosed |
| EP-2447769-A1 | COMPOSITION FOR FORMING THERMOSET FILM HAVING PHOTO ALIGNMENT PROPERTIES | Nissan Chemical Industries, Ltd. (JP) | 2012-05-02 | — | — | EP | disclosed |
| US-20120082805-A1 | COMPOSITION FOR FORMING THERMOSET FILM HAVING PHOTO ALIGNMENT PROPERTIES | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-05 | — | — | US | disclosed |
| EP-2336256-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM WITH ONIUM GROUP | Nissan Chemical Industries, Ltd. (JP) | 2011-06-22 | — | — | EP | disclosed |
| US-20110143149-A1 | RESIST UNDERLAYER FILM FORMING COMPOSITION CONTAINING SILICONE HAVING ONIUM GROUP | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2011-06-16 | — | — | US | disclosed |
| EP-1858955-A1 | PROCESSES USING ALPHA, OMEGA-DIFUNCTIONAL ALDARAMIDES AS MONOMERS AND CROSSLINKERS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2007-11-28 | — | — | EP | disclosed |
| WO-2006091901-A1 | PROCESSES USING ALPHA, OMEGA-DIFUNCTIONAL ALDARAMIDES AS MONOMERS AND CROSSLINKERS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2006-08-31 | — | — | WO | disclosed |
| US-6130330-A | Process for preparing macropolycyclic polyamines | CLARIANT GMBH (DE) | 2000-10-10 | — | — | US | disclosed |
| EP-0940403-A2 | Process for the preparation of macropolycyclic polyamines | Clariant GmbH (DE) | 1999-09-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110143149-A1 | RESIST UNDERLAYER FILM FORMING COMPOSITION CONTAINING SILICONE HAVING ONIUM GROUP | SRR, KDM2B, MSR1 | GAA 1407/4885ALDH1A1 3585/4885CYP3A4 1550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.